Global Veterinary Anti-infectives Market to Hit USD 18.23 Bn by 2035 | CAGR 6.81%

Read more about this report- Global Veterinary Anti-infectives Market to Hit USD 18.23 Bn by 2035 | CAGR 6.81%

• Metatech Infographics: Smart Data, Market Segments, and Future Trends at a Glance.
• The Veterinary Anti-infectives Market took USD 8.83 billion in 2024 and USD 9.43 billion in 2025 and is predicted to grow to USD 18.23 billion by 2035 with a CAGR of approximately 6.81% between 2025 and 2035.
• The growth in the veterinary anti-infectives market is due to increasing demand in healthier and disease-free livestock, and the rising prevalence level of infectious diseases in companion and livestock animals. Among the major limitations are the increasing worry about the event of antimicrobial resistance and regulatory limitations on the use of antibiotics on livestock. The future opportunities are in the creation of new antivirals, antifungals, and antiparasitic treatments, and digital animal health surveillance tools to communicate suitable and timely intervention.
• The veterinary anti-infectives market is classified based on such products as antibiotics, antivirals, antifungals, and antiparasitic, among others. The types of animals include companion animals, livestock animals, and aquatic animals. Administration routes include oral, injectable, and topical options, and distribution channels are retail pharmacies, online pharmacies, and so on. The end users include veterinary hospitals and clinics, home care, research and academic institutions, and farms and animal husbandry units.
• Across the product lines, antibiotics are the largest product category because they are widely used in the prevention and treatment of bacterial infection in animals, particularly in livestock, to help them remain productive and to prevent outbreaks of disease. The trend of companion animal treatment is on the rise as a result of the growing number of pets and the concern over their well-being.
• Technological usage of digital health monitoring, tele-veterinary care, and AI-assisted diagnosis is being adopted in the veterinary anti-infectives market, ensuring quicker diagnosis and treatment of an infection, especially in the field of livestock and aquaculture.
• This is because the increase in global uptake is due to the rising veterinary healthcare expenditure, the improvement of animal disease monitoring infrastructure, and the rising awareness of animal health and food safety standards. North America and Europe dominate the market, but the Asia-Pacific region has great growth potential since livestock production and the adoption of pets are growing.
• The major participants in the veterinary anti-infectives market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim Animal Health. These companies are contributing to market growth by developing new products, developing distribution channels, and making strategic partnerships to enhance animal health performance and minimize infection risk.